GE HealthCare Technologies Inc.
General ticker "GEHC" information:
- Sector: Health Care
- Industry: Medical - Healthcare Information Services
- Capitalization: $35.0B (TTM average)
GE HealthCare Technologies Inc. follows the US Stock Market performance with the rate: 66.4%.
Estimated limits based on current volatility of 1.6%: low 69.75$, high 71.97$
Factors to consider:
- Company included in S&P500 list
- Company included in NASDAQ-100 index
- Company pays dividends (irregularly): last record date 2026-01-09, amount 0.04$ (Y0.06%)
- Total employees count: 50000 as of 2022
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [70.33$, 98.69$]
- 2026-12-31 to 2027-12-31 estimated range: [72.50$, 102.21$]
Financial Metrics affecting the GEHC estimates:
- Negative: with PPE of 18.1 at the end of fiscal year the price was high
- Positive: 7.67 < Operating profit margin, % of 13.39
- Positive: 1.87 < Return on assets ratio (scaled to [-100,100]) of 5.51
- Positive: Industry inventory ratio change (median), % of 0 <= 0
- Positive: -4.43 < Investing cash flow per share per price, % of -2.76
- Negative: Inventory ratio change, % of 9.79 > 0.80
Short-term GEHC quotes
Long-term GEHC plot with estimates
Financial data
| YTD | 2024-12-31 | 2025-12-31 |
|---|---|---|
| Operating Revenue | $19,672.00MM | $20,625.00MM |
| Operating Expenses | $17,047.00MM | $17,863.00MM |
| Operating Income | $2,625.00MM | $2,762.00MM |
| Non-Operating Income | $-44.00MM | $6.00MM |
| Interest Expense | $505.00MM | $450.00MM |
| R&D Expense | $1,311.00MM | $1,260.00MM |
| Income(Loss) | $2,581.00MM | $2,768.00MM |
| Taxes | $531.00MM | $614.00MM |
| Profit(Loss)* | $1,993.00MM | $2,084.00MM |
| Stockholders Equity | $8,447.00MM | $10,379.00MM |
| Inventory | $1,939.00MM | $2,234.00MM |
| Assets | $33,089.00MM | $36,906.00MM |
| Operating Cash Flow | $1,951.00MM | $1,988.00MM |
| Capital expenditure | $401.00MM | $482.00MM |
| Investing Cash Flow | $-914.00MM | $-1,047.00MM |
| Financing Cash Flow | $-573.00MM | $617.00MM |
| Earnings Per Share** | $4.37 | $4.56 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.